Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Cosmet Dermatol ; 21(5): 1986-1988, 2022 May.
Artigo em Inglês | MEDLINE | ID: mdl-35176192

RESUMO

A novel fractional laser system with differential-wavelength modified optically pumped semiconductor technology can produce a pure 585 nm wavelength as pulsed dye laser, which has been used to treat vascular, pigmented skin lesions. Besides, this new laser modality also showed promising results for verruca plana in our experience. In this brief report, we present three cases of facial flat warts treated by this novel 585 nm diode laser.


Assuntos
Lasers de Corante , Lasers de Estado Sólido , Verrugas , Face , Humanos , Lasers de Corante/uso terapêutico , Lasers Semicondutores/uso terapêutico , Lasers de Estado Sólido/uso terapêutico , Resultado do Tratamento , Verrugas/cirurgia
3.
Acta Derm Venereol ; 85(3): 236-9, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16040409

RESUMO

Tazarotene and calcipotriol are both effective in the treatment of psoriasis. An investigator-blind, bilateral comparison of 44 lesion pairs in 19 patients was conducted to evaluate the efficacy, side effects and duration of therapeutic effects of once-daily tazarotene 0.1% gel plus petrolatum with twice-daily calcipotriol 0.005% ointment in plaque psoriasis. It consisted of a 12-week treatment phase, followed by a 4-week post-treatment observation phase. At the end of the treatment phase, tazarotene-petrolatum was as effective as calcipotriol in both objective and subjective overall efficacy assessment. Calcipotriol had a significantly greater effect in reducing erythema than tazarotene-petrolatum at weeks 2-8. At week 16, tazarotene-petrolatum demonstrated a significantly better maintenance effect in all parameters. Local irritation was noted only in tazarotene-petrolatum-treated lesions. Once-daily tazarotene 0.1% gel plus petrolatum was as effective as twice-daily calcipotriol 0.005% ointment in the treatment of plaque psoriasis, but had a better maintenance effect after the cessation of therapy.


Assuntos
Calcitriol/análogos & derivados , Fármacos Dermatológicos/administração & dosagem , Ácidos Nicotínicos/administração & dosagem , Psoríase/tratamento farmacológico , Administração Cutânea , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Calcitriol/administração & dosagem , Criança , Método Duplo-Cego , Esquema de Medicação , Feminino , Géis , Humanos , Masculino , Pessoa de Meia-Idade , Pomadas , Vaselina/administração & dosagem , Estudos Prospectivos , Psoríase/patologia , Índice de Gravidade de Doença , Resultado do Tratamento
4.
Clin Immunol ; 117(1): 65-72, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16043414

RESUMO

The aim of this study was to investigate the expression of interleukin-20 (IL-20) and its receptors on psoriatic skin by immunohistochemical analysis and to evaluate the correlation of CD8-positive T lymphocytes with epidermal proliferation. Overexpression of IL-20 and its receptors was detected in the keratinocytes of the lesional skin of psoriasis and spongiotic dermatitis. The expression pattern of IL-20 spreads throughout the whole layer of epidermis, while IL-19 was expressed in up to three or four layers suprabasally. The serum level of IL-20 in psoriatic patients was significantly lower than that in healthy controls. IL-20 upregulated KGF transcripts on CD8-positive T cells. We hypothesize that overexpression of IL-20 is correlated with keratinocyte proliferation that acts through their receptor complex expressed by keratinocytes themselves. Furthermore, IL-20 can stimulate CD8-positive lymphocytes to produce KGF, which may contribute to sustaining the hyperproliferative status of the keratinocytes.


Assuntos
Interleucinas/metabolismo , Psoríase/metabolismo , Receptores de Interleucina/metabolismo , Pele/metabolismo , Linfócitos T CD8-Positivos/imunologia , Linfócitos T CD8-Positivos/metabolismo , Fator 7 de Crescimento de Fibroblastos , Fatores de Crescimento de Fibroblastos/imunologia , Fatores de Crescimento de Fibroblastos/metabolismo , Humanos , Imuno-Histoquímica , Interleucina-10/imunologia , Interleucina-10/metabolismo , Interleucinas/sangue , Interleucinas/imunologia , Queratinócitos/imunologia , Queratinócitos/metabolismo , Psoríase/sangue , Psoríase/imunologia , Receptores de Interleucina/imunologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Pele/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA